TY  -  
T1  - Evaluation of the antitumor efficacy of peptide-coated conditionally replicating adenovirus (PeptiCRAd) 
SN  -  /  
UR  - URN:NBN:fi-fe201801151328; http://hdl.handle.net/10138/161051 
T3  -  
A1  - Vainionpää, Teea 
A2  -  
PB  - Helsingfors universitet 
Y1  - 2016 
LA  - eng 
AB  - Oncolytic viruses have been extensively studied for the treatment of cancer. They are genetically engineered viruses, which are able to selectively infect and kill the cancer cells causing no harm to normal cells. Adenoviruses are the most commonly used viruses in the gene therapy field and their oncolytic variants are currently under evaluation in many clinical trials. The cell killing properties of oncolytic adenoviruses against the cancer cells have been known for a long time. In addition, it... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - PeptiCRAd; oncolytic adenovirus; antitumor effect; onkolyyttinen adenovirus; kasvainta tuhoavat vaikutukset; Biofarmaci; Biopharmacy; Biofarmasia 
N1  -   
PP  -  
ER  -